EMLA cream–induced allergic contact dermatitis: a role for prilocaine as an immunogen Binod K. Thakur, MD, MRCP, (UK), Mandakolathur R. Murali, MD Journal of Allergy and Clinical Immunology Volume 95, Issue 3, Pages 776-778 (March 1995) DOI: 10.1016/S0091-6749(95)70187-7 Copyright © 1995 Mosby, Inc. Terms and Conditions
FIG. 1 Patients back showing results of patch testing to ingredients of EMLA cream. Top row , left to right: 1% Arlatone, 1% lidocaine, normal saline solution, and petrolatum. Middle row, left to right: 1% prilocaine, 1% Carbopol, 2% Arlatone, and 2% lidocaine. Bottom row, left to right of midline: 2% prilocaine and 2% Carbopol. Note: Patient had positive patch test responses to 1% and 2% prilocaine and negative responses to other ingredients of EMLA cream and to controls, inflammatory sequelae of PHN could be seen over the left lower chest wall Journal of Allergy and Clinical Immunology 1995 95, 776-778DOI: (10.1016/S0091-6749(95)70187-7) Copyright © 1995 Mosby, Inc. Terms and Conditions